{
  "id": "clinical#screening_cues_c5ea8445",
  "content": "304.10 severe lorazepam use disorder is also given. When more than one\nsubstance is judged to play a significant role in the development of anx-\niety symptoms, each should be listed separately (e.g., 292.89 methylphe-\nnidate-induced anxiety disorder, with onset during intoxication; 292.89\nsalbutamol-induced anxiety disorder, with onset after medication use).\nICD-10-CM. The name of the substance/medication-induced anx-\niety disorder begins with the specific substance (e.g., cocaine, salbu-\ntamol) that is presumed to be causing the anxiety symptoms. The\ndiagnostic code is selected from the table included in the criteria set,\nwhich is based on the drug class and presence or absence of a co-\nmorbid substance use disorder. For substances that do not fit into\nany of the classes (e.g., salbutamol), the code for “other substance”\nshould be used; and in cases in which a substance is judged to be an\netiological factor but the specific class of substance is unknown, the\ncategory “unknown substance” should be used.\nWhen recording the name of the disorder, the comorbid substance\nuse disorder (if any) is listed first, followed by the word “with,” fol-\nlowed by the name of the substance-induced anxiety disorder, followed\nAnxiety Disorder Due to Another Medical Condition 127",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues 304.10 severe lorazepam use disorder is also given. When more than one\nsubstance is judged to play a significant role in the development of anx-\niety symptoms, each should be listed separately (e.g., 292.89 methylphe-\nnidate-induced anxiety disorder, with onset during intoxication; 292.89\nsalbutamol-induced anxiety disorder, with onset after medication use).\nICD-10-CM. The name of the substance/medication-induced anx-\niety disorder begins with the specific substance (e.g., cocaine, salbu-\ntamol) that is presumed to be causing the anxiety symptoms. The\ndiagnostic code is selected from the table included in the criteria set,\nwhich is based on the drug class and presence or absence of a co-\nmorbid substance use disorder. For substances that do not fit into\nany of the classes (e.g., salbutamol), the code for “other substance”\nshould be used; and in cases in which a substance is judged to be an\netiological factor but the specific class of substance is unknown, the\ncategory “unknown substance” should be used.\nWhen recording the name of the disorder, the comorbid substance\nuse disorder (if any) is listed first, followed by the word “with,” fol-\nlowed by the name of the substance-induced anxiety disorder, followed\nAnxiety Disorder Due to Another Medical Condition 127 304.10 severe lorazepam use disorder is also given. when more than one\nsubstance is judged to play a significant role in the development of anx-\niety symptoms, each should be listed separately (e.g., 292.89 methylphe-\nni..."
}